Livzon Pharmaceutical Group Inc. (HKG:1513)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
28.40
+1.08 (3.95%)
At close: Mar 6, 2026

HKG:1513 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Jan '22 Jan '21
Market Capitalization
31,71932,67531,16831,03939,65739,381
Market Cap Growth
2.08%4.83%0.41%-21.73%0.70%27.23%
Enterprise Value
25,22826,36325,00825,20733,28332,171
Last Close Price
28.4026.5421.9422.3422.8423.17
PE Ratio
13.5514.9014.4814.3818.1919.33
PS Ratio
2.452.602.282.172.683.15
PB Ratio
1.892.061.921.842.262.43
P/TBV Ratio
2.172.302.102.082.562.82
P/FCF Ratio
11.4412.7511.6514.9854.4621.90
P/OCF Ratio
9.0810.318.719.9016.9815.35
EV/Sales Ratio
1.882.101.831.772.252.58
EV/EBITDA Ratio
7.708.038.288.7011.5811.19
EV/EBIT Ratio
8.819.7711.8111.5414.1413.35
EV/FCF Ratio
9.1010.299.3512.1745.7117.89
Debt / Equity Ratio
0.260.270.280.240.190.14
Debt / EBITDA Ratio
1.361.281.501.401.140.80
Debt / FCF Ratio
1.551.651.711.984.541.27
Net Debt / Equity Ratio
-0.46-0.46-0.49-0.46-0.46-0.59
Net Debt / EBITDA Ratio
-2.48-2.25-2.65-2.69-2.83-3.32
Net Debt / FCF Ratio
-2.81-2.88-2.99-3.77-11.18-5.32
Asset Turnover
0.480.480.500.540.560.55
Inventory Turnover
2.312.092.332.472.742.82
Quick Ratio
1.951.871.861.971.832.13
Current Ratio
2.252.152.132.302.122.40
Return on Equity (ROE)
16.43%15.53%12.78%13.37%13.97%16.45%
Return on Assets (ROA)
6.38%6.40%4.81%5.11%5.58%6.58%
Return on Invested Capital (ROIC)
26.24%26.92%19.70%20.64%25.12%33.56%
Return on Capital Employed (ROCE)
14.70%15.10%11.30%11.10%12.40%14.00%
Earnings Yield
7.38%6.71%6.91%6.95%5.50%5.17%
FCF Yield
8.74%7.85%8.58%6.67%1.84%4.57%
Dividend Yield
4.24%4.41%6.78%8.09%6.99%6.41%
Payout Ratio
48.57%65.03%81.36%83.33%70.81%64.14%
Buyback Yield / Dilution
2.91%1.10%0.56%0.04%0.25%-0.41%
Total Shareholder Return
7.15%5.51%7.34%8.13%7.23%6.00%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.